Latest Breaking News On - Ken inchausti - Page 6 : vimarsana.com

Ocugen Inc Announces Nirdosh Jagota, Ph D as Senior Vice

MALVERN, Pa., Jan. 24, 2022 (GLOBE NEWSWIRE) Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and.

United statesUttar pradeshShankar musunuriNirdosh jagotaKen inchaustiRegulatory affairsUniversity of toledoInvestor relations communicationsOcugen incUniversity of georgiaExchange commissionIndian institute of technologyGlobal regulatory affairsSenior vice presidentExecutive vice presidentChief regulatory officer

Ocugen, Inc Announces Inducement Grants Under Nasdaq

MALVERN, Pa., Jan. 21, 2022 (GLOBE NEWSWIRE) Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and.

Ken inchaustiExchange commissionInvestor relations communicationsOcugen incCompensation committeeNasdaq listing ruleBharat biotechPrivate securities litigation reform actInvestor relationsNasdaq ocgn

COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety

COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshShankar musunuriChiron behringKen inchaustiNational institute of virologyWorld health organizationInvestor relations communicationsDrug administrationIndian council of medical researchOcugen incExchange commissionHealth canadaClinical developmentDelta plusBharat biotech

COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesAndhra pradeshShankar musunuriChiron behringKen inchaustiNational institute of virologyWorld health organizationInvestor relations communicationsDrug administrationIndian council of medical researchOcugen incExchange commissionHealth canadaClinical developmentDelta plusBharat biotech

Ocugen, Inc to Present at Upcoming H C Wainwright Bioconnect Conference

Ocugen, Inc to Present at Upcoming H C Wainwright Bioconnect Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Shankar musunuriHc wainwright bioconnectKen inchaustiExchange commissionInvestor relations communicationsDrug administrationHealth canadaOcugen incBioconnect conferenceBharat biotechPrivate securities litigation reform actInvestor relations